SEC Form 4 · accession 0000921895-16-005149
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jul 8, 2016
Accepted (ET)
Jul 12, 2016 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 8, 2016 | S | 21,190 | $1.80 | D | 4,965,856 | D | |
| Common Stock | Jul 11, 2016 | S | 800 | $1.80 | D | 4,965,056 | D |
Table II — derivative securities
No Table II lines on this filing.